Adequate Pain Management and Sedation in the Neonate: a Fine Balance
- 110 Downloads
Purpose of review
With heightened awareness of long-term neurocognitive effects of pain and stress in the neonatal population, increased focus has been placed on pain assessment as well as potential effects of routinely administered analgesics/sedatives in our neonatal intensive care units (NICUs). Our goal was to review recently published literature on current pain assessment practices, novel approaches to management, pharmacogenomics in the neonate, and risks of commonly used medications.
There is an increasing trend in the administration of analgesics and sedatives in NICUs, despite reports of the negative effects these medications may have on neonatal brain development. As in the adult world, studies are finding that pharmacogenomics has the potential to play a significant role in adequate pain control and sedation in the individual neonatal patient. Due to increased reports of adverse effects of commonly used medications such as morphine and midazolam, new pharmacologic agents are being evaluated in the neonatal population as possibly safer alternatives.
There have been significant advances in our knowledge of pain and sedation in the neonate, ranging from a better understanding of long-term neurocognitive effects of pain in neonatal brain development to the role of pharmacogenomics in the NICU setting. These developments have opened the door for continued learning and investigation into the ideal management of neonatal pain and sedation.
KeywordsNeonatal intensive care unit NICU Neonatal pain Neonatal sedation
Compliance with Ethical Standards
Conflict of Interest
Lauren Cummings declares that she has no conflict of interest. Tamorah Lewis declares that she has no conflict of interest. Brian S. Carter declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 5.Carbajal R, Eriksson M, Courtois E, Boyle E, Avila-Alvarez A, Andersen RD, et al. Sedation and analgesia practices in neonatal intensive care units (EUROPAIN): results from a prospective cohort study. Lancet Respir Med. 2015;3(10):796–812. https://doi.org/10.1016/S2213-2600(15)00331-8.CrossRefPubMedGoogle Scholar
- 10.Liu Y, Huang X, Luo B, Peng W. Effects of combined oral sucrose and nonnutritive sucking (NNS) on procedural pain of NICU newborns, 2001 to 2016: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017;96(6):e6108. https://doi.org/10.1097/MD.0000000000006108.CrossRefGoogle Scholar
- 16.Hummel P. Psychometric evaluation of the neonatal pain, agitation, and sedation (N-PASS) scale in infants and children up to age 36 months. Pediatr Nurs. 2017;43(4):175–84.Google Scholar
- 17.• Anand KJS, Eriksson M, Boyle EM, Avila-Alvarez A, Andersen RD, Sarafidis K, et al. Assessment of continuous pain in newborns admitted to NICUs in 18 European countries. Acta Paediatr. 2017;106(8):1248–59. https://doi.org/10.1111/apa.13810This is a multicenter prospective observational study that spans over 18 European countries that evaluated the current state of pain management within 243 NICUs. They tracked the use of mechanical ventilation, sedation, analgesia, neuromuscular blockade, and frequency of pain assessments in 6648 neonates over an 8-month period. They found that only 31.8% of the total neonates received assessments of continuous pain at least one time during their admission. Only 10% of these neonates received daily assessments of continuous pain. The assessments of continuous pain varied between countries, occuring most commonly in France (100%). The NICUs with increased surgical admissions, pain management guidelines, and nursing champions performed assessments of continous pain more frequently.CrossRefPubMedGoogle Scholar
- 23.Elens L, Norman E, Matic M, Rane A, Fellman V, van Schaik RH. Genetic predisposition to poor opioid response in preterm infants: impact of KCNJ6 and COMT polymorphisms on pain relief after endotracheal intubation. Ther Drug Monit. 2016;38(4):525–33. https://doi.org/10.1097/FTD.0000000000000301.CrossRefPubMedGoogle Scholar
- 25.• Zwicker JG, Miller SP, Grunau RE, Chau V, Brant R, Studholme C, et al. Smaller cerebellar growth and poorer neurodevelopmental outcomes in very preterm infants exposed to neonatal morphine. J Pediatr. 2016;172:81–87 e82. https://doi.org/10.1016/j.jpeds.2015.12.024This study utilized magnetric resonance imaging (MRI) in order to evaluate early brain development in a prospective cohort of 188 preterm infants (24–32 weeks of gestational age) admitted to the neonatal intensive care unit. All participants underwent brain MRI scans without sedation within the first weeks of life and at term-equivalent age. At 18-month corrected age, 136 of the original participants received standardized motor and cognitive assessments. Increased morphine exposure was associated with a decrease in cerebellar volume, after adjustments were made for total brain volume and various clinical confounders. They also found that morphine exposure was significantly associated with poor motor and cognitive outcomes.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Kocek M, Wilcox R, Crank C, Patra K. Evaluation of the relationship between opioid exposure in extremely low birth weight infants in the neonatal intensive care unit and neurodevelopmental outcome at 2 years. Early Hum Dev. 2016;92:29–32. https://doi.org/10.1016/j.earlhumdev.2015.11.001.CrossRefPubMedGoogle Scholar